We don't know they a still wont. Bit silly if they did think that way (I doubt it) as these results quite clearly indicate you can have a non-surgical intervention and get faster and arguably better results (better pain scores at six months, faster strength returns, etc):
I wonder if Paul and our new Chair have been playing a little hardball on negotiations now they have the BioHOrizons revenue streams in place:
It did quite convincingly meet its primary and outperformed surgery significantly on Dash scores:
We don't know they a still wont. Bit silly if they did think...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 38.0¢ | $10.3K | 26.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3551 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 14559 | 1 |
View Market Depth
| Last trade - 13.46pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
38.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 38.0¢ | 38.5¢ | 38.0¢ | 18729 | ||
| Last updated 13.46pm 16/05/2024 ? | |||||
| OCC (ASX) Chart |